[EN] TOXIC ALDEHYDE RELATED DISEASES AND TREATMENT<br/>[FR] MALADIES LIÉES À UN ALDÉHYDE TOXIQUE ET TRAITEMENT
申请人:ALDEXA THERAPEUTICS INC
公开号:WO2014116836A2
公开(公告)日:2014-07-31
The present invention provides for the treatment, prevention, and/or reduction of a risk of a disease, disorder, or condition in which aldehyde toxicity is implicated in the pathogenesis, including ocular disorders, skin disorders, conditions associated with injurious effects from blister agents, and autoimmune, inflammatory, neurological and cardiovascular diseases by the use of a primary amine to scavenge toxic aldehydes, such as MDA and HNE.